カテゴリー： 世界, 医療/バイオ, Infiniti Research TechNavio

世界のバイオチップ市場2023年-2027年

【英語タイトル】Global Biochips Market 2023-2027

Technavioが出版した調査資料（IRTNTR75193-23）・商品コード：IRTNTR75193-23
・発行会社（調査会社）：Technavio
・発行日：2023年4月12日
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Technavio社の市場調査資料によると、世界のバイオチップ市場規模は2022年から2027年の間に43,273.01百万ドルへ達し、予測期間中に年平均25.15％成長する見通しです。こちらの資料では、バイオチップの世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別（バイオテクノロジー・製薬企業、病院・診断センター、学術・研究機関）分析、技術別（マイクロアレイ、マイクロ流体力学）分析、顧客状況、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米、アメリカ、中国、ロシア、イギリス、フランス）分析、成長要因・課題・動向、企業状況、企業分析など、以下の構成でお届けします。また、当書では、Agilent Technologies Inc.、Analis sa、Arrayit Corp.、BICO Group AB、Bio Rad Laboratories Inc.、Boao Bio Group Co. Ltd.、Dynamic Biosensors GmbH、Eden Tech、Greiner Bio One International GmbH、Illumina Inc.、INNOPSYSなどの企業情報が含まれております。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界のバイオチップ市場規模：エンドユーザー別
- バイオテクノロジー・製薬企業における市場規模
- 病院・診断センターにおける市場規模
- 学術・研究機関における市場規模
・世界のバイオチップ市場規模：技術別
- マイクロアレイにおける市場規模
- マイクロ流体力学における市場規模
・顧客状況
・世界のバイオチップ市場規模：地域別
- 北米のバイオチップ市場規模
- ヨーロッパのバイオチップ市場規模
- アジア太平洋のバイオチップ市場規模
- 中東・アフリカのバイオチップ市場規模
- 南米のバイオチップ市場規模
- アメリカのバイオチップ市場規模
- 中国のバイオチップ市場規模
- ロシアのバイオチップ市場規模
- イギリスのバイオチップ市場規模
- フランスのバイオチップ市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータを調査、統合、および総括することにより、バイオチップ市場の詳細な全体像を提供します。主要産業のインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査資料は、正確なバイオチップ市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

バイオチップの世界市場 2023-2027

Technavio社は、バイオチップ市場をモニターしており、2022年から2027年にかけて43,273.01百万米ドルの成長が予測され、予測期間中のCAGRは25.15%で加速すると予測しています。

当レポートでは、バイオチップ市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、創薬におけるマイクロアレイ・バイオチップの用途拡大、連携戦略をとる市場プレイヤーのプレゼンス向上、個別化医薬品の利用拡大などです。

Technavioのバイオチップ市場は以下のようにセグメント化されています：

・エンドユーザー別：
– バイオテクノロジー・製薬企業
– 病院・診断センター
– 学術・研究機関

・技術別：
– マイクロアレイ
– マイクロフルイディクス

・地域別：
– 北米
– ヨーロッパ
– アジア太平洋
– 中東・アフリカ
– 南米

本調査では、ケミカルマイクロアレイ技術の利用の増加が、今後数年間のバイオチップ市場の成長を促進する主要な理由の1つであると特定しています。また、新興のLoc技術とバイオインフォマティクスソフトウェア産業の成長は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

バイオチップ市場に関する弊社のレポートは以下の分野をカバーしています：
– バイオチップ市場のサイジング
– バイオチップ市場予測
– バイオチップ市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Agilent Technologies Inc., Analis sa, Arrayit Corp., BICO Group AB, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., Dynamic Biosensors GmbH, Eden Tech, Greiner Bio-One International GmbH, Illumina Inc., INNOPSYS, Micronit BV, Nutcracker Therapeutics Inc., Perkin Elmer Inc., QIAGEN NV, Randox Laboratories Ltd., Sphere Fluidics Ltd., Takara Holdings Inc., IDEX Corp., and Thermo Fisher Scientific Inc..などの企業情報が含まれています。また、バイオチップ市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、合成、要約することにより、市場の詳細な姿を提示します。主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biochips market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global biochips market 2017 – 2021 ($ million)
o 4.2 By End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – By End-user Segment 2017 – 2021 ($ million)
o 4.3 By Technology Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – By Technology Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Biotechnology and pharmaceutical companies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Biotechnology and pharmaceutical companies – Year-over-year growth 2022-2027 (%)
o 6.4 Hospitals and diagnostics centers – Market size and forecast 2022-2027
o Exhibit 38: Chart on Hospitals and diagnostics centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hospitals and diagnostics centers – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hospitals and diagnostics centers – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hospitals and diagnostics centers – Year-over-year growth 2022-2027 (%)
o 6.5 Academic and research institutes – Market size and forecast 2022-2027
o Exhibit 42: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 48: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Technology – Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 50: Chart on Comparison by Technology
o Exhibit 51: Data Table on Comparison by Technology
o 7.3 Microarrays – Market size and forecast 2022-2027
o Exhibit 52: Chart on Microarrays – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Microarrays – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Microarrays – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Microarrays – Year-over-year growth 2022-2027 (%)
o 7.4 Microfluidics – Market size and forecast 2022-2027
o Exhibit 56: Chart on Microfluidics – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Microfluidics – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Microfluidics – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Microfluidics – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Technology
o Exhibit 60: Market opportunity by Technology ($ million)
o Exhibit 61: Data Table on Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 APAC – Market size and forecast 2022-2027
o Exhibit 75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on APAC – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
o 9.6 Middle East and Africa – Market size and forecast 2022-2027
o Exhibit 79: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
o 9.7 South America – Market size and forecast 2022-2027
o Exhibit 83: Chart on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on South America – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on South America – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on South America – Year-over-year growth 2022-2027 (%)
o 9.8 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Russia – Market size and forecast 2022-2027
o Exhibit 95: Chart on Russia – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Russia – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Russia – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Russia – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 France – Market size and forecast 2022-2027
o Exhibit 103: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 115: Agilent Technologies Inc. – Overview
o Exhibit 116: Agilent Technologies Inc. – Business segments
o Exhibit 117: Agilent Technologies Inc. – Key offerings
o Exhibit 118: Agilent Technologies Inc. – Segment focus
o 12.4 Arrayit Corp.
o Exhibit 119: Arrayit Corp. – Overview
o Exhibit 120: Arrayit Corp. – Product / Service
o Exhibit 121: Arrayit Corp. – Key offerings
o 12.5 BICO Group AB
o Exhibit 122: BICO Group AB – Overview
o Exhibit 123: BICO Group AB – Business segments
o Exhibit 124: BICO Group AB – Key offerings
o Exhibit 125: BICO Group AB – Segment focus
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 126: Bio Rad Laboratories Inc. – Overview
o Exhibit 127: Bio Rad Laboratories Inc. – Business segments
o Exhibit 128: Bio Rad Laboratories Inc. – Key news
o Exhibit 129: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 130: Bio Rad Laboratories Inc. – Segment focus
o 12.7 Boao Bio Group Co. Ltd.
o Exhibit 131: Boao Bio Group Co. Ltd. – Overview
o Exhibit 132: Boao Bio Group Co. Ltd. – Product / Service
o Exhibit 133: Boao Bio Group Co. Ltd. – Key offerings
o 12.8 Eden Tech
o Exhibit 134: Eden Tech – Overview
o Exhibit 135: Eden Tech – Product / Service
o Exhibit 136: Eden Tech – Key offerings
o 12.9 Greiner Bio One International GmbH
o Exhibit 137: Greiner Bio One International GmbH – Overview
o Exhibit 138: Greiner Bio One International GmbH – Product / Service
o Exhibit 139: Greiner Bio One International GmbH – Key offerings
o 12.10 Illumina Inc.
o Exhibit 140: Illumina Inc. – Overview
o Exhibit 141: Illumina Inc. – Business segments
o Exhibit 142: Illumina Inc. – Key news
o Exhibit 143: Illumina Inc. – Key offerings
o Exhibit 144: Illumina Inc. – Segment focus
o 12.11 INNOPSYS
o Exhibit 145: INNOPSYS – Overview
o Exhibit 146: INNOPSYS – Product / Service
o Exhibit 147: INNOPSYS – Key offerings
o 12.12 Nutcracker Therapeutics Inc.
o Exhibit 148: Nutcracker Therapeutics Inc. – Overview
o Exhibit 149: Nutcracker Therapeutics Inc. – Product / Service
o Exhibit 150: Nutcracker Therapeutics Inc. – Key offerings
o 12.13 Perkin Elmer Inc.
o Exhibit 151: Perkin Elmer Inc. – Overview
o Exhibit 152: Perkin Elmer Inc. – Business segments
o Exhibit 153: Perkin Elmer Inc. – Key news
o Exhibit 154: Perkin Elmer Inc. – Key offerings
o Exhibit 155: Perkin Elmer Inc. – Segment focus
o 12.14 QIAGEN NV
o Exhibit 156: QIAGEN NV – Overview
o Exhibit 157: QIAGEN NV – Product / Service
o Exhibit 158: QIAGEN NV – Key news
o Exhibit 159: QIAGEN NV – Key offerings
o 12.15 Sphere Fluidics Ltd.
o Exhibit 160: Sphere Fluidics Ltd. – Overview
o Exhibit 161: Sphere Fluidics Ltd. – Product / Service
o Exhibit 162: Sphere Fluidics Ltd. – Key offerings
o 12.16 Takara Holdings Inc.
o Exhibit 163: Takara Holdings Inc. – Overview
o Exhibit 164: Takara Holdings Inc. – Business segments
o Exhibit 165: Takara Holdings Inc. – Key offerings
o Exhibit 166: Takara Holdings Inc. – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 167: Thermo Fisher Scientific Inc. – Overview
o Exhibit 168: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 169: Thermo Fisher Scientific Inc. – Key news
o Exhibit 170: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 171: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Technology
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global biochips market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – By End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – By Technology Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Biotechnology and pharmaceutical companies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Biotechnology and pharmaceutical companies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospitals and diagnostics centers – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospitals and diagnostics centers – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospitals and diagnostics centers – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospitals and diagnostics centers – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Technology – Market share 2022-2027 (%)
Exhibits49: Data Table on Technology – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Technology
Exhibits51: Data Table on Comparison by Technology
Exhibits52: Chart on Microarrays – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Microarrays – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Microarrays – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Microarrays – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Microfluidics – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Microfluidics – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Microfluidics – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Microfluidics – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Technology ($ million)
Exhibits61: Data Table on Market opportunity by Technology ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on APAC – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on South America – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on South America – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on South America – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on South America – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Russia – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Russia – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Russia – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Russia – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Agilent Technologies Inc. – Overview
Exhibits116: Agilent Technologies Inc. – Business segments
Exhibits117: Agilent Technologies Inc. – Key offerings
Exhibits118: Agilent Technologies Inc. – Segment focus
Exhibits119: Arrayit Corp. – Overview
Exhibits120: Arrayit Corp. – Product / Service
Exhibits121: Arrayit Corp. – Key offerings
Exhibits122: BICO Group AB – Overview
Exhibits123: BICO Group AB – Business segments
Exhibits124: BICO Group AB – Key offerings
Exhibits125: BICO Group AB – Segment focus
Exhibits126: Bio Rad Laboratories Inc. – Overview
Exhibits127: Bio Rad Laboratories Inc. – Business segments
Exhibits128: Bio Rad Laboratories Inc. – Key news
Exhibits129: Bio Rad Laboratories Inc. – Key offerings
Exhibits130: Bio Rad Laboratories Inc. – Segment focus
Exhibits131: Boao Bio Group Co. Ltd. – Overview
Exhibits132: Boao Bio Group Co. Ltd. – Product / Service
Exhibits133: Boao Bio Group Co. Ltd. – Key offerings
Exhibits134: Eden Tech – Overview
Exhibits135: Eden Tech – Product / Service
Exhibits136: Eden Tech – Key offerings
Exhibits137: Greiner Bio One International GmbH – Overview
Exhibits138: Greiner Bio One International GmbH – Product / Service
Exhibits139: Greiner Bio One International GmbH – Key offerings
Exhibits140: Illumina Inc. – Overview
Exhibits141: Illumina Inc. – Business segments
Exhibits142: Illumina Inc. – Key news
Exhibits143: Illumina Inc. – Key offerings
Exhibits144: Illumina Inc. – Segment focus
Exhibits145: INNOPSYS – Overview
Exhibits146: INNOPSYS – Product / Service
Exhibits147: INNOPSYS – Key offerings
Exhibits148: Nutcracker Therapeutics Inc. – Overview
Exhibits149: Nutcracker Therapeutics Inc. – Product / Service
Exhibits150: Nutcracker Therapeutics Inc. – Key offerings
Exhibits151: Perkin Elmer Inc. – Overview
Exhibits152: Perkin Elmer Inc. – Business segments
Exhibits153: Perkin Elmer Inc. – Key news
Exhibits154: Perkin Elmer Inc. – Key offerings
Exhibits155: Perkin Elmer Inc. – Segment focus
Exhibits156: QIAGEN NV – Overview
Exhibits157: QIAGEN NV – Product / Service
Exhibits158: QIAGEN NV – Key news
Exhibits159: QIAGEN NV – Key offerings
Exhibits160: Sphere Fluidics Ltd. – Overview
Exhibits161: Sphere Fluidics Ltd. – Product / Service
Exhibits162: Sphere Fluidics Ltd. – Key offerings
Exhibits163: Takara Holdings Inc. – Overview
Exhibits164: Takara Holdings Inc. – Business segments
Exhibits165: Takara Holdings Inc. – Key offerings
Exhibits166: Takara Holdings Inc. – Segment focus
Exhibits167: Thermo Fisher Scientific Inc. – Overview
Exhibits168: Thermo Fisher Scientific Inc. – Business segments
Exhibits169: Thermo Fisher Scientific Inc. – Key news
Exhibits170: Thermo Fisher Scientific Inc. – Key offerings
Exhibits171: Thermo Fisher Scientific Inc. – Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations



★調査レポート[世界のバイオチップ市場2023年-2027年] (コード：IRTNTR75193-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバイオチップ市場2023年-2027年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の電子顕微鏡市場2023年～2027年
  • 世界の半導体パッケージング材料市場2023年～2027年
  • 世界の歯科装置市場2023年～2027年
  • 世界の補聴器3Dプリンティング装置市場2023年～2027年
  • 世界のエピネフリン自動注射器市場2023年～2027年
  • 世界の電動車椅子市場2023年-2027年
  • 世界の脳・組織酸素測定装置市場2023年～2027年
  • 世界の局所コルチコステロイド市場2023年～2027年
  • 世界の歯科用手術機器市場2023年～2027年
  • 世界の麻酔用ラリンジアルマスク市場2023年-2027年

    • ◆H&Iグローバルリサーチのお客様（例）◆